Lack of orders, lack of network, a shortage of money: There are many reasons why startups go bankrupt. To prevent this, the Technology and Innovation Center Giessen (TIG) offers young companies support programs, internal networking and affordable commercial space – and all of this in the economic stronghold of Central Hessen.
One litre of blood plasma can be used in 17 different product lines against rare diseases: The Marburg-based biotechnology company CSL Behring uses the plasma to produce drugs for the treatment of hereditary angioedema (HAE) and haemophilia.
Dr. Nadine Biedenkopf, a scientist from Marburg, is researching substances against dangerous viruses such as Ebola. Silvestrol gives hope.
In addition to traditional radiotherapy, chemotherapy and surgery, targeted and patient-tailored drugs expand the arsenal of therapeutic options.
Many people around the world snore. However, if left untreated, snoring can be a sign of sleep apnea, which can lead to an increased risk of heart attacks and strokes. To prevent such outcomes, Marburg-based experts are researching therapeutic methods to treat sleep and respiratory disorders.
Digitalization is changing the healthcare system: E-Health combines the latest IT technologies with medicine. The aim is to offer modern, patient-friendly care.
Early detection of cancer can save lives. Laser microdissection enables specific cell examinations and precise cancer research.
Researchers in Central Hessen, Germany, are taking up the fight against Antibiotic resistance, including a search for new ways to combat infectious diseases.